GSK’s new RSV jab set to achieve blockbuster status
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.GSK is…
RSV vaccine sales for elderly to top $10B by 2030 in G7 (NYSE:PFE)
Hailshadow/iStock via Getty Images Ahead of the world's first immunization drive against respiratory syncytial virus (RSV), a new report from…
